US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

92.62

+1.481.62%

Post-market: 92.620.00000.00%19:30 EDT

Volume:1.29M

Turnover:117.82M

Market Cap:6.13B

PE:-45.76

High:93.88

Open:91.00

Low:86.00

Close:91.15

52wk High:115.52

52wk Low:14.67

Shares:66.21M

Float Shares:56.65M

Volume Ratio:1.60

T/O Rate:2.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0242

EPS(LYR):-1.8483

ROE:-18.23%

ROA:-12.95%

PB:5.52

PE(LYR):-50.11

Loading ...

Overview Company News Filings

Does Oruka Therapeutics' (ORKA) $1 Billion Shelf Plan Reframe Its Long-Term Capital Strategy?

Simply Wall St.

BRIEF-Oruka Therapeutics May Offer Up To $1 Billion Of Securities From Time To Time - SEC Filing

Oruka Therapeutics Files $1 Billion Mixed Shelf

MT Newswires Live

Oruka Therapeutics files $1B mixed securities shelf

Oruka Therapeutics Inc - May Offer up to $1 Bln of Securities From Time to Time - SEC Filing

THOMSON REUTERS

ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors

Piper Sandler Sticks to Their Buy Rating for Oruka Therapeutics (ORKA)

Stock Track | Oruka Therapeutics Soars 9% in Pre-market After Leerink Partners Raises Price Target to $86

Oruka Therapeutics' Shares Hit 52-Week High, 4Q Loss Narrower Than Expected

Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades

Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA)

Oruka Therapeutics (ORKA) Receives a Buy from Guggenheim

Oruka Therapeutics Inc : Stifel Raises Target Price to $72 From $47

THOMSON REUTERS

Jefferies Remains a Buy on Oruka Therapeutics (ORKA)

Oruka’s ORKA-001 Extension Study Builds Long-Term Case in Psoriasis Market

Oruka Therapeutics COO Laura Lee Sandler Disposes of Common Shares

Oruka Therapeutics Inc expected to post a loss of 63 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ORKA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ORKA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","market":"US","secType":"STK","nameCN":"ORUKA THERAPEUTICS INC","latestPrice":92.62,"timestamp":1788206400000,"preClose":91.145,"halted":0,"volume":1292888,"hourTrading":{"tag":"盘后","latestPrice":92.62,"preClose":92.62,"latestTime":"19:30 EDT","volume":177203,"amount":16412157.83761,"timestamp":1788219002233,"change":0,"changeRate":0,"amplitude":0.000648},"delay":0,"changeRate":0.016183005101761024,"floatShares":56648688,"shares":66209699,"eps":-2.024183,"marketStatus":"Closed","change":1.475,"latestTime":"08-31 16:00:00 EDT","open":91,"high":93.88,"low":86,"amount":117819797.41408,"amplitude":0.086456,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.024183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":871012800000,"exchange":"NASDAQ","adjPreClose":91.145,"preHourTrading":{"tag":"盘前","latestPrice":89.6,"preClose":91.145,"latestTime":"08:45 EDT","volume":452,"amount":40765.194768,"timestamp":1788180338507,"change":-1.545,"changeRate":-0.016951,"amplitude":0.021881},"postHourTrading":{"tag":"盘后","latestPrice":92.62,"preClose":92.62,"latestTime":"19:30 EDT","volume":177203,"amount":16412157.83761,"timestamp":1788219002233,"change":0,"changeRate":0,"amplitude":0.000648},"volumeRatio":1.603603,"impliedVol":1.0664,"impliedVolPercentile":0.7131},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ORKA\",,,,,undefined,":{"symbol":"ORKA","floatShares":56648688,"roa":"-12.95%","roe":"-18.23%","lyrEps":-1.84833,"volumeRatio":1.603603,"shares":66209699,"dividePrice":0,"high":93.88,"amplitude":0.086456,"preClose":91.145,"low":86,"week52Low":14.665,"pbRate":"5.52","week52High":115.515,"institutionHeld":0.89,"latestPrice":92.62,"eps":-2.024183,"divideRate":0,"volume":1292888,"delay":0,"ttmEps":-2.024183,"open":91,"prevYearClose":30.31,"prevWeekClose":91.145,"prevMonthClose":96.51,"prevQuarterClose":95.17,"fiveDayClose":102.42,"twentyDayClose":94.79,"sixtyDayClose":62.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ORKA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"ORKA","fiscalQuarterEnding":"2026/06","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2026-05-13","symbol":"ORKA","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2026-03-12","symbol":"ORKA","fiscalQuarterEnding":"2025/12","expectedEps":-0.61,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-11-12","symbol":"ORKA","fiscalQuarterEnding":"2025/09","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2024-09-03","symbol":"ORKA","defaultRemindTime":1725370200000,"type":"split","dateTimestamp":1725336000000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ORKA\",market:\"US\",,,undefined,":[{"executeDate":"2024-08-29","recordDate":"2024-08-26","paymentDate":"2024-08-28","value":1.613,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ORKA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":14,"updateTime":1767931200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ORKA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ORKA","date":"2026-08-28","current":-45.756732,"percent":0.062331,"low":-56.341471,"twenty":-32.366532,"median":-12.608863,"eighty":-4.699811,"high":-2.779284,"avg":-17.47578,"sd":15.202174,"marketCap":6391884341},"quantilePoints":[{"date":"2025-03-14","current":-4.566552,"twenty":-4.600166,"median":-4.533759,"eighty":-4.155287,"marketCap":417087281},{"date":"2025-03-21","current":-4.898591,"twenty":-4.788731,"median":-4.634189,"eighty":-4.465422,"marketCap":447414094},{"date":"2025-03-28","current":-4.898591,"twenty":-4.90187,"median":-4.734621,"eighty":-4.543597,"marketCap":447414094},{"date":"2025-04-04","current":-3.656521,"twenty":-4.90187,"median":-4.68543,"eighty":-4.155287,"marketCap":333969349},{"date":"2025-04-11","current":-3.021139,"twenty":-4.898591,"median":-4.546056,"eighty":-3.567158,"marketCap":275936558},{"date":"2025-04-17","current":-3.529445,"twenty":-4.883833,"median":-4.205819,"eighty":-3.28595,"marketCap":322362791},{"date":"2025-04-25","current":-4.304201,"twenty":-4.810047,"median":-4.25501,"eighty":-3.440082,"marketCap":393125355},{"date":"2025-05-02","current":-4.136132,"twenty":-4.747739,"median":-4.214018,"eighty":-3.521247,"marketCap":377774745},{"date":"2025-05-09","current":-3.996758,"twenty":-4.714945,"median":-4.198946,"eighty":-3.605691,"marketCap":365044972},{"date":"2025-05-16","current":-3.364967,"twenty":-4.682151,"median":-4.136132,"eighty":-3.605691,"marketCap":354187224},{"date":"2025-05-23","current":-3.980336,"twenty":-4.607544,"median":-4.002451,"eighty":-3.625269,"marketCap":418959306},{"date":"2025-05-30","current":-4.215101,"twenty":-4.558354,"median":-4.038702,"eighty":-3.660839,"marketCap":443670043},{"date":"2025-06-06","current":-4.336041,"twenty":-4.541137,"median":-4.079934,"eighty":-3.705732,"marketCap":456399816},{"date":"2025-06-13","current":-4.57792,"twenty":-4.558354,"median":-4.136132,"eighty":-3.769048,"marketCap":481859363},{"date":"2025-06-20","current":-4.261343,"twenty":-4.543597,"median":-4.170639,"eighty":-3.777968,"marketCap":448537309},{"date":"2025-06-27","current":-4.136846,"twenty":-4.523383,"median":-4.154632,"eighty":-3.785238,"marketCap":435433131},{"date":"2025-07-03","current":-4.48188,"twenty":-4.48188,"median":-4.154632,"eighty":-3.808193,"marketCap":471750426},{"date":"2025-07-11","current":-5.004766,"twenty":-4.566552,"median":-4.184867,"eighty":-3.812292,"marketCap":526787975},{"date":"2025-07-18","current":-5.463625,"twenty":-4.701827,"median":-4.197316,"eighty":-3.861483,"marketCap":575086233},{"date":"2025-07-25","current":-5.061679,"twenty":-4.767415,"median":-4.21456,"eighty":-3.877182,"marketCap":532778457},{"date":"2025-08-01","current":-4.834028,"twenty":-4.898055,"median":-4.257786,"eighty":-3.894967,"marketCap":508816530},{"date":"2025-08-08","current":-4.862484,"twenty":-4.898591,"median":-4.281656,"eighty":-3.898524,"marketCap":511811771},{"date":"2025-08-15","current":-5.221398,"twenty":-4.905169,"median":-4.336041,"eighty":-3.910674,"marketCap":561761175},{"date":"2025-08-22","current":-5.148299,"twenty":-5.001209,"median":-4.36364,"eighty":-3.910674,"marketCap":553896518},{"date":"2025-08-29","current":-5.315383,"twenty":-5.050833,"median":-4.460538,"eighty":-3.918873,"marketCap":571872876},{"date":"2025-09-05","current":-5.210955,"twenty":-5.062675,"median":-4.474766,"eighty":-3.936742,"marketCap":560637652},{"date":"2025-09-12","current":-5.621705,"twenty":-5.07235,"median":-4.48188,"eighty":-3.943016,"marketCap":604829531},{"date":"2025-09-19","current":-5.771385,"twenty":-5.152476,"median":-4.546056,"eighty":-3.972962,"marketCap":620933352},{"date":"2025-09-26","current":-5.238803,"twenty":-5.191462,"median":-4.609934,"eighty":-3.980356,"marketCap":563633712},{"date":"2025-10-03","current":-6.676428,"twenty":-5.243928,"median":-4.669033,"eighty":-3.986032,"marketCap":718305289},{"date":"2025-10-10","current":-11.49024,"twenty":-5.309118,"median":-4.714571,"eighty":-3.994896,"marketCap":1236215032},{"date":"2025-10-17","current":-11.944453,"twenty":-5.339054,"median":-4.762887,"eighty":-3.996758,"marketCap":1285083024},{"date":"2025-10-24","current":-12.200791,"twenty":-5.382217,"median":-4.835807,"eighty":-4.005866,"marketCap":1312661989},{"date":"2025-10-31","current":-12.641513,"twenty":-5.468786,"median":-4.862484,"eighty":-4.057038,"marketCap":1360078456},{"date":"2025-11-07","current":-12.717965,"twenty":-5.593858,"median":-4.890941,"eighty":-4.0778,"marketCap":1368303762},{"date":"2025-11-14","current":-11.869655,"twenty":-5.811068,"median":-4.898591,"eighty":-4.08882,"marketCap":1277035540},{"date":"2025-11-21","current":-11.960253,"twenty":-6.69801,"median":-4.937534,"eighty":-4.127114,"marketCap":1306565171},{"date":"2025-11-28","current":-13.338408,"twenty":-7.110152,"median":-4.992317,"eighty":-4.136132,"marketCap":1457117883},{"date":"2025-12-05","current":-13.706211,"twenty":-11.478098,"median":-5.012542,"eighty":-4.13656,"marketCap":1497297545},{"date":"2025-12-12","current":-13.387153,"twenty":-11.950773,"median":-5.056256,"eighty":-4.136846,"marketCap":1462442898},{"date":"2025-12-19","current":-12.474292,"twenty":-12.178774,"median":-5.061679,"eighty":-4.147518,"marketCap":1362719880},{"date":"2025-12-26","current":-14.233544,"twenty":-12.273678,"median":-5.068237,"eighty":-4.154632,"marketCap":1554904531},{"date":"2026-01-02","current":-13.431466,"twenty":-12.335062,"median":-5.068793,"eighty":-4.160323,"marketCap":1467283821},{"date":"2026-01-09","current":-11.698803,"twenty":-12.335062,"median":-5.136174,"eighty":-4.183799,"marketCap":1278003724},{"date":"2026-01-16","current":-14.401935,"twenty":-12.358192,"median":-5.155261,"eighty":-4.187731,"marketCap":1573300040},{"date":"2026-01-23","current":-15.744639,"twenty":-12.45713,"median":-5.171947,"eighty":-4.192073,"marketCap":1719980012},{"date":"2026-01-30","current":-15.624992,"twenty":-12.523037,"median":-5.216176,"eighty":-4.197316,"marketCap":1706909520},{"date":"2026-02-06","current":-13.923348,"twenty":-12.576213,"median":-5.238803,"eighty":-4.205819,"marketCap":1521018069},{"date":"2026-02-13","current":-14.463974,"twenty":-12.717965,"median":-5.287536,"eighty":-4.214018,"marketCap":1580077332},{"date":"2026-02-20","current":-14.366484,"twenty":-12.919201,"median":-5.310162,"eighty":-4.214884,"marketCap":1569427301},{"date":"2026-02-27","current":-15.208444,"twenty":-13.338408,"median":-5.315383,"eighty":-4.240712,"marketCap":1661404842},{"date":"2026-03-06","current":-14.698837,"twenty":-13.396016,"median":-5.355415,"eighty":-4.255652,"marketCap":1605734225},{"date":"2026-03-13","current":-14.507853,"twenty":-13.648603,"median":-5.374559,"eighty":-4.260632,"marketCap":1584870685},{"date":"2026-03-20","current":-18.241416,"twenty":-13.893215,"median":-5.41633,"eighty":-4.275953,"marketCap":1923247264},{"date":"2026-03-27","current":-21.361535,"twenty":-14.059834,"median":-5.48943,"eighty":-4.282885,"marketCap":2252210732},{"date":"2026-04-02","current":-23.696925,"twenty":-14.201638,"median":-5.513424,"eighty":-4.296003,"marketCap":2498437907},{"date":"2026-04-10","current":-29.885474,"twenty":-14.284061,"median":-5.632148,"eighty":-4.323305,"marketCap":3150915147},{"date":"2026-04-17","current":-31.516018,"twenty":-14.426751,"median":-5.771385,"eighty":-4.336613,"marketCap":3322828285},{"date":"2026-04-24","current":-32.251183,"twenty":-14.559692,"median":-6.578962,"eighty":-4.336995,"marketCap":3400338954},{"date":"2026-05-01","current":-32.570171,"twenty":-14.666931,"median":-6.714718,"eighty":-4.368969,"marketCap":3433970886},{"date":"2026-05-08","current":-36.374119,"twenty":-14.779487,"median":-7.118506,"eighty":-4.40896,"marketCap":3835032479},{"date":"2026-05-15","current":-33.151059,"twenty":-15.005487,"median":-11.013542,"eighty":-4.444887,"marketCap":3853943253},{"date":"2026-05-22","current":-30.448133,"twenty":-15.220852,"median":-11.594521,"eighty":-4.464806,"marketCap":3539717207},{"date":"2026-05-29","current":-30.079787,"twenty":-15.26162,"median":-11.787176,"eighty":-4.470498,"marketCap":3496895615},{"date":"2026-06-05","current":-32.31061,"twenty":-15.550545,"median":-11.911508,"eighty":-4.477612,"marketCap":3756237650},{"date":"2026-06-12","current":-35.521957,"twenty":-15.752615,"median":-11.97259,"eighty":-4.48188,"marketCap":4129569555},{"date":"2026-06-18","current":-36.772255,"twenty":-18.655866,"median":-12.082116,"eighty":-4.48188,"marketCap":4274921718},{"date":"2026-06-26","current":-44.943291,"twenty":-19.50544,"median":-12.254757,"eighty":-4.492256,"marketCap":5224837309},{"date":"2026-07-02","current":-48.398471,"twenty":-20.901036,"median":-12.28174,"eighty":-4.533759,"marketCap":5626515902},{"date":"2026-07-10","current":-45.794116,"twenty":-23.696925,"median":-12.328056,"eighty":-4.546056,"marketCap":5323749155},{"date":"2026-07-17","current":-43.080813,"twenty":-28.475782,"median":-12.340203,"eighty":-4.566552,"marketCap":5008316867},{"date":"2026-07-24","current":-47.703285,"twenty":-29.138337,"median":-12.358192,"eighty":-4.57792,"marketCap":5545697686},{"date":"2026-07-31","current":-50.769369,"twenty":-29.924337,"median":-12.387424,"eighty":-4.629142,"marketCap":5902142203},{"date":"2026-08-07","current":-51.059895,"twenty":-30.381727,"median":-12.474292,"eighty":-4.653329,"marketCap":5935916980},{"date":"2026-08-14","current":-53.870179,"twenty":-31.249154,"median":-12.51639,"eighty":-4.666461,"marketCap":7158592655},{"date":"2026-08-21","current":-52.245903,"twenty":-31.638621,"median":-12.55157,"eighty":-4.687203,"marketCap":6942749037},{"date":"2026-08-28","current":-48.10051,"twenty":-32.366532,"median":-12.608863,"eighty":-4.699811,"marketCap":6391884341}],"updateTime":1788226662851},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ORKA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2625462811","title":"Does Oruka Therapeutics' (ORKA) $1 Billion Shelf Plan Reframe Its Long-Term Capital Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625462811","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625462811?lang=en_us&edition=fundamental","pubTime":"2026-04-06 03:21","pubTimestamp":1775416898,"startTime":"0","endTime":"0","summary":"In early April 2026, Oruka Therapeutics, Inc. filed an omnibus shelf registration that would allow it to issue up to US$1 billion of common stock, preferred stock, depositary shares, and warrants over time.\nThis broad financing framework gives Oruka Therapeutics flexible access to multiple types of capital, which could be used for future clinical, operational, or transactional initiatives.\nNext, we’ll examine how this flexible US$1 billion shelf registration may influence Oruka Therapeutics’...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/does-oruka-therapeutics-orka-1-billion-shelf-plan-reframe-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-orka/oruka-therapeutics/news/does-oruka-therapeutics-orka-1-billion-shelf-plan-reframe-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624602680","title":"BRIEF-Oruka Therapeutics May Offer Up To $1 Billion Of Securities From Time To Time - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624602680","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624602680?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:40","pubTimestamp":1775166036,"startTime":"0","endTime":"0","summary":"BRIEF-Oruka Therapeutics May Offer Up To $1 Billion Of Securities From Time To Time - SEC FilingApril 2  - Oruka Therapeutics Inc ORKA.O:ORUKA THERAPEUTICS INC - MAY OFFER UP TO $1 BILLION OF SECURITIES FROM TIME TO TIME - SEC FILINGSource text: [ID:n0001213900-26-039332]Further company coverage: ORKA.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624343687","title":"Oruka Therapeutics Files $1 Billion Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2624343687","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624343687?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:46","pubTimestamp":1775162767,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics  filed a mixed shelf registration statement late Thursday with the US Securities and Exchange Commission for the sale of up to $1 billion of its securities from time to time.The securities cover common stock, preferred stock, depository shares and warrants, according to the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ORKA","BK4139","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624939682","title":"Oruka Therapeutics files $1B mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2624939682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624939682?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:15","pubTimestamp":1775160915,"startTime":"0","endTime":"0","summary":"16:12 EDT Oruka Therapeutics (ORKA) files $1B mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oruka-therapeutics-files-1b-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oruka-therapeutics-files-1b-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","ORKA","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624684006","title":"Oruka Therapeutics Inc - May Offer up to $1 Bln of Securities From Time to Time - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624684006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624684006?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:07","pubTimestamp":1775160450,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nFWN40L0WF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624645548","title":"ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2624645548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624645548?lang=en_us&edition=fundamental","pubTime":"2026-04-02 00:30","pubTimestamp":1775061050,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. The study, titled “Phase 1, First-in-human, Double-Blind, Pla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/orka-001-phase-1-completion-what-orukas-first-in-human-milestone-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/orka-001-phase-1-completion-what-orukas-first-in-human-milestone-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA","ISBC","BK4211","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621691320","title":"Piper Sandler Sticks to Their Buy Rating for Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621691320","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621691320?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:16","pubTimestamp":1774351015,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Oruka Therapeutics today and set a price target of $75.00. Rahimi covers the Health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133084132","title":"Stock Track | Oruka Therapeutics Soars 9% in Pre-market After Leerink Partners Raises Price Target to $86","url":"https://stock-news.laohu8.com/highlight/detail?id=1133084132","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133084132?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:45","pubTimestamp":1773665152,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc's stock surged 9.00% in pre-market trading on Monday, following a significant analyst upgrade that boosted investor confidence in the company's prospects.The sharp increase...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619116717","title":"Oruka Therapeutics' Shares Hit 52-Week High, 4Q Loss Narrower Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2619116717","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619116717?lang=en_us&edition=fundamental","pubTime":"2026-03-13 23:33","pubTimestamp":1773415980,"startTime":"0","endTime":"0","summary":"Shares of Oruka Therapeutics gained after the company logged a narrower fourth-quarter loss than Wall Street expected as it made progress with trials for its leading programs.The stock climbed 22% to $39 on Friday after touching a 52-week high of $39.66 earlier in the trading session. Shares have more than tripled in the past year.The clinical-stage biotechnology company posted a net loss of $29.6 million, or 45 cents a share, compared with a loss of $25.8 million, or 49 cents a share, a year earlier. Analysts polled by FactSet expected a loss of 64 cents a share.The company, which is developing treatments for chronic skin diseases, said it completed enrollment for a study of one of its leading programs and now expects to report data in the second quarter. Oruka also said it is starting a Phase 2 study for a potential plaque psoriasis treatment and expects to report data from the trial next year.\"We are very pleased with the progress of both our co-lead programs as we advance into what","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","ORKA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190686525","title":"Stock Track | Oruka Therapeutics Soars 5.25% Intraday on Multiple Analyst Upgrades","url":"https://stock-news.laohu8.com/highlight/detail?id=1190686525","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190686525?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:32","pubTimestamp":1773408757,"startTime":"0","endTime":"0","summary":"Shares of Oruka Therapeutics Inc (ORKA) surged 5.25% during intraday trading on Friday, driven by a wave of positive analyst actions.The stock's rise follows several bullish reports from financial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619197263","title":"Analysts Offer Insights on Healthcare Companies: Citius Oncology (CTOR) and Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619197263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619197263?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:50","pubTimestamp":1773406204,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Citius Oncology (CTOR – Research Report) and Oruka T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-citius-oncology-ctor-and-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-citius-oncology-ctor-and-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","LU0128526141.USD","HCSG","ORKA","XLV","LABU","LU0029874061.USD","BK4581","XBI","BK4585","BK4139","CTOR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194520","title":"Oruka Therapeutics (ORKA) Receives a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194520","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194520?lang=en_us&edition=fundamental","pubTime":"2026-03-13 19:56","pubTimestamp":1773403009,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Yatin Suneja from Guggenheim reiterated a Buy rating on Oruka Therapeutics, with a price target of $60.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oruka-therapeutics-orka-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oruka-therapeutics-orka-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619196245","title":"Oruka Therapeutics Inc : Stifel Raises Target Price to $72 From $47","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196245","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619196245?lang=en_us&edition=fundamental","pubTime":"2026-03-13 18:55","pubTimestamp":1773399344,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nFWN4010SK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ORKA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618928106","title":"Jefferies Remains a Buy on Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928106?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:28","pubTimestamp":1773235719,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Oruka Therapeutics today and set a price target of $45.00. Song covers the Healthcare secto...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","ORKA","XLV","XBI","BK4581","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617631222","title":"Oruka’s ORKA-001 Extension Study Builds Long-Term Case in Psoriasis Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2617631222","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617631222?lang=en_us&edition=fundamental","pubTime":"2026-03-07 00:33","pubTimestamp":1772814818,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. Oruka Therapeutics, Inc. is running an extension study called...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/orukas-orka-001-extension-study-builds-long-term-case-in-psoriasis-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/orukas-orka-001-extension-study-builds-long-term-case-in-psoriasis-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616367042","title":"Oruka Therapeutics COO Laura Lee Sandler Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616367042","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616367042?lang=en_us&edition=fundamental","pubTime":"2026-03-03 07:48","pubTimestamp":1772495305,"startTime":"0","endTime":"0","summary":"Laura Lee Sandler, Chief Operating Officer of Oruka Therapeutics, Inc., reported a disposal of common shares of Oruka Therapeutics, Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL7g1PxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Oruka Therapeutics COO Laura Lee Sandler Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616355073","title":"Oruka Therapeutics Inc  expected to post a loss of 63 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616355073","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616355073?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:07","pubTimestamp":1772449636,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics Inc  expected to post a loss of63cents a share - Earnings Preview Oruka Therapeutics Inc ORKA.OQ ORKA.O is expected to  show no change in quarterly revenue when it reports  results ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL8N3ZQ12N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORKA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":117,"code":"91000000","status":"200"}]}}